Ignite Creation Date:
2024-07-17 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06477484
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2024-06-06
Brief Title:
Blood Biomarkers for Screening of Alzheimers Disease
Sponsor:
Peking University First Hospital
Organization:
Peking University First Hospital
Study Overview
Official Title:
Blood-based Biomarkers for Early Alzheimers Disease Screening
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to estimate the screen performance of blood biomarkers of interest Aβ40 and Aβ42 P-Tau181 P-Tau217 GFAP and NfL in patients with Alzheimers disease AD mild cognitive impairment due to AD and cognitively normal individuals The main questions it aims to answer are
to identify core blood biomarker suitable for early screening of AD
to establish a comprehensive model for the early identification of AD
to identify core blood biomarker suitable for early screening of AD
to establish a comprehensive model for the early identification of AD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None